The second goal of the current studies was to test this hypothesis by comparing the prevalence of these biomarkers in asymptomatic, CD4+ T cell-matched HIV+TB− subjects at low-risk or high-risk for TB. The gene discussed is CD4; the disease is tuberculosis.